Smith, T. J. & Hegedus, L. Graves’ disease. N. Engl. J. Med. 375, 1552–1565 (2016).

Article  PubMed  Google Scholar 

Adams, D. D. Pathogenesis of the hyperthyroidism of Graves’s disease. Br. Med. J. 1, 1015–1019 (1965).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee, H. J., Li, C. W., Hammerstad, S. S., Stefan, M. & Tomer, Y. Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J. Autoimmun. 64, 82–90 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brix, T. H., Kyvik, K. O., Christensen, K. & Hegedus, L. Evidence for a major role of heredity in Graves’ disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab. 86, 930–934 (2001).

CAS  PubMed  Google Scholar 

Simmonds, M. J. et al. Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves’ disease. J. Clin. Endocrinol. Metab. 91, 1056–1061 (2006).

Article  CAS  PubMed  Google Scholar 

Inoue, N. et al. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies. J. Clin. Immunol. 32, 1243–1252 (2012).

Article  CAS  PubMed  Google Scholar 

Khong, J. J. et al. Pooled genome wide association detects association upstream of FCRL3 with Graves’ disease. BMC Genomics 17, 939 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Zhao, S. X. et al. A refined study of FCRL genes from a genome-wide association study for Graves’ disease. PLoS One 8, e57758 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hasham, A. & Tomer, Y. Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol. Res. 54, 204–213 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faustino, L. C. et al. Precision medicine in Graves’ disease: CD40 gene variants predict clinical response to an anti-CD40 monoclonal antibody. Front. Endocrinol. 12, 691781 (2021).

Article  Google Scholar 

Kahaly, G. J. et al. A novel anti-CD40 monoclonal antibody, iscalimab, for control of Graves hyperthyroidism-a proof-of-concept trial. J. Clin. Endocrinol. Metab. 105, dgz013 (2020).

Article  PubMed  Google Scholar 

Bufalo, N. E. et al. Polymorphisms of the genes CTLA4, PTPN22, CD40, and PPARG and their roles in Graves’ disease: susceptibility and clinical features. Endocrine 71, 104–112 (2021).

Article  CAS  PubMed  Google Scholar 

Shi, T. T. et al. Alterations in the intestinal microbiota of patients with severe and active Graves’ orbitopathy: a cross-sectional study. J. Endocrinol. Invest. 42, 967–978 (2019).

Article  CAS  PubMed  Google Scholar 

Biscarini, F. et al. Gut microbiome associated with graves disease and graves orbitopathy: the INDIGO multicenter European study. J. Clin. Endocrinol. Metab. 108, 2065–2077 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Pearce, S. H. S. et al. Antigen-specific immunotherapy with thyrotropin receptor peptides in Graves’ hyperthyroidism: a phase I study. Thyroid 29, 1003–1011 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chin, Y. H. et al. Prevalence of thyroid eye disease in Graves’ disease: a meta-analysis and systematic review. Clin. Endocrinol. 93, 363–374 (2020).

Article  Google Scholar 

Fatourechi, V. Thyroid dermopathy and acropachy. Best Pract. Res. Clin. Endocrinol. Metab. 26, 553–565 (2012).

Article  CAS  PubMed  Google Scholar 

Bahn, R. S. Current insights into the pathogenesis of Graves’ ophthalmopathy. Horm. Metab. Res. 47, 773–778 (2015).

Article  CAS  PubMed  Google Scholar 

Davies, T. F. et al. Graves’ disease. Nat. Rev. Dis. Prim. 6, 52 (2020).

Article  PubMed  Google Scholar 

Kriss, J. P. Pathogenesis and treatment of pretibial myxedema. Endocrinol. Metab. Clin. North Am. 16, 409–415 (1987).

Article  CAS  PubMed  Google Scholar 

Fatourechi, V., Pajouhi, M. & Fransway, A. F. Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases. Medicine 73, 1–7 (1994).

Article  CAS  PubMed  Google Scholar 

Bartley, G. B. Rundle and his curve. Arch. Ophthalmol. 129, 356–358 (2011).

Article  PubMed  Google Scholar 

Bartalena, L. & Fatourechi, V. Extrathyroidal manifestations of Graves’ disease: a 2014 update. J. Endocrinol. Invest. 37, 691–700 (2014).

Article  CAS  PubMed  Google Scholar 

Bartalena, L. & Tanda, M. L. Current concepts regarding Graves’ orbitopathy. J. Intern. Med. 292, 692–716 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mourits, M. P., Prummel, M. F., Wiersinga, W. M. & Koornneef, L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin. Endocrinol. 47, 9–14 (1997).

Article  CAS  Google Scholar 

Bartalena, L. et al. The 2021 European Group on Graves’ Orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur. J. Endocrinol. 185, G43–G67 (2021).

Article  CAS  PubMed  Google Scholar 

Perros, P., Crombie, A. L. & Kendall-Taylor, P. Natural history of thyroid associated ophthalmopathy. Clin. Endocrinol. 42, 45–50 (1995).

Article  CAS  Google Scholar 

McLeod, D. S. & Cooper, D. S. The incidence and prevalence of thyroid autoimmunity. Endocrine 42, 252–265 (2012).

Article  CAS  PubMed  Google Scholar 

Taylor, P. N. et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301–316 (2018).

Article  PubMed  Google Scholar 

Schuh, A. et al. Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III). Br. J. Ophthalmol. 108, 294–300 (2023).

Article  Google Scholar 

Tanda, M. L. et al. Prevalence and natural history of Graves’ orbitopathy in a large series of patients with newly diagnosed graves’ hyperthyroidism seen at a single center. J. Clin. Endocrinol. Metab. 98, 1443–1449 (2013).

Article  CAS  PubMed  Google Scholar 

Tomer, Y. Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics. Annu. Rev. Pathol. 9, 147–156 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Limbach, M. et al. Epigenetic profiling in CD4+ and CD8+ T cells from Graves’ disease patients reveals changes in genes associated with T cell receptor signaling. J. Autoimmun. 67, 46–56 (2016).

Article  CAS